Source: startupticker ch

InterAx: Large Pharma Company Selects InterAx Biotech

InterAx Biotech announced today that it has entered an agreement with Lundbeck A/S to enable the in-depth characterization of drug candidates using the proprietary InterAx systems biology platform.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Christopher Prior's photo - CEO of InterAx

CEO

Christopher Prior

CEO Approval Rating

83/100

Read more